We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
INTRAROSA (Theramex Australia Pty Ltd)
Product name
INTRAROSA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (175 working days)
Registration type
NCE/NBE
Indication
INTRAROSA is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.